Skip to main content

Table 2 Logistic model for prediction of colistin rather than tigecycline use of the 294 enrolled patients

From: Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumanniiin a critical setting: a matched cohort analysis

Variable

Odds ratio

95% confidence interval

p-value

Age (year)

0.99

0.98 – 1.01

.69

Male

1.83

1.02 – 3.31

.04

Baseline creatinine (mg/dL)

0.76

0.57 – 1.01

.06

Chronic kidney disease × Baseline creatinine

1.42

1.09 – 1.84

.01

Insulin use

1.55

0.82 – 2.93

.18

Malignancy

40.43

9.31 – 175.52

<.001

  1. Estimated area under the ROC curve = 0.74.